JAZZ logo

Jazz Pharmaceuticals (JAZZ)

Profile

Full Name

Jazz Pharmaceuticals plc

Ticker Symbol

JAZZ

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Ireland

IPO

June 1, 2007

Indexes

Not included

Website

http://www.jazzpharma.com

Employees

2800

Key Details

Price

$102.78(+1.21%)

Market cap

$6.24B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.07B(+6.12% YoY)

Annual EPS

$8.65(+41.80% YoY)

PE ratio

11.69

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$102.78
JAZZ price is $102.78

30-Day Relative Volume

0.65
JAZZ 30-day relative volume is 0.65

Price Performance

Price Most recent change

+1.21%
JAZZ price was up +1.21% on Apr 17, 2025

Price YTD change

-16.54%
JAZZ price is down -16.54% since January 1st

Price 1-year change

-4.03%
JAZZ price is down -4.03% year-on-year

Price 3-year change

-38.55%
JAZZ price is down -38.55% over the past 3 years

Price Range

Price All-time high

$194.73
JAZZ price is currently -47.22% below its historical high of $194.73

Price 3-year low

$95.49
JAZZ price is currently +7.63% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$6.24B
JAZZ market capitalization is $6.24 billion

Market cap 3-year change

-40.1%
JAZZ market capitalization is down -40.1% over the past 3 years

Market cap All-time high

$11.82B
JAZZ market capitalization is currently -47.21% below its historical high of $11.82 billion

Market cap sector rank

90.45%
JAZZ market capitalization is higher than 90.45% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-3.64%
JAZZ shares outstanding is down -3.64% year-on-year

Shares Outstanding 3-Year Change

-2.43%
JAZZ shares outstanding is down -2.43% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.70
JAZZ beta is 0.70

200-day SMA

$118.45
JAZZ price is currently -13.23% below its 200-day simple moving average

50-day SMA

$128.48
JAZZ price is currently -20.00% below its 50-day simple moving average

RSI

31.87
JAZZ 14-day relative strength index is 31.87

Volume

0.65
JAZZ 30-day relative volume is 0.65

ATR

$5.54
JAZZ average true range is $5.54

10-day Historical Volatility

73.34%
JAZZ 10-day historical volatility is 73.34%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$4.07B
JAZZ annual revenue is $4.07 billion

Revenue Analysts estimate

$4.29B
JAZZ annual revenue is currently -5.19% lower than the consensus analysts' forecast

Revenue 1-year change

+6.12%
JAZZ annual revenue is up +6.12% year-on-year

Revenue Sector rank

90.92%
JAZZ annual revenue is higher than 90.92% of companies in Healthcare sector

EPS

EPS

$8.65
JAZZ annual earnings per share is $8.65

EPS Analysts estimate

$23.31
JAZZ annual earnings per share is currently -62.88% lower than the consensus analysts' forecast

EPS 1-year change

+41.8%
JAZZ annual earnings per share is up +41.8% year-on-year

EPS Sector rank

97.76%
JAZZ annual earnings per share is higher than 97.76% of companies in Healthcare sector

Profit

Gross profit

$3.62B
JAZZ annual gross profit is $3.62 billion

Gross margin

89.05%
JAZZ annual gross profit margin is 89.05%

Operating profit

$726.63M
JAZZ annual operating income is $726.63 million

Operating margin

17.86%
JAZZ annual operating profit margin is 17.86%

Net income

$560.12M
JAZZ annual net profit is $560.12 million

Net margin

13.77%
JAZZ annual net profit margin is 13.77%

Expenses

Total expenses

$3.34B
JAZZ annual total expenses is $3.34 billion

Operating expenses

$2.90B
JAZZ annual total operating expenses is $2.90 billion

Cost of goods sold

$445.71M
JAZZ annual cost of goods sold is $445.71 million

Selling, general & administrative expenses

$1.39B
JAZZ annual SGA is $1.39 billion

Depreciation and amortization

$660.07M
JAZZ annual depreciation & amortization is $660.07 million

Interest expense

$238.10M
JAZZ annual interest expense is $238.10 million

Income tax

-$91.43M
JAZZ annual income tax is -$91.43 million

EBIT & EBITDA

EBIT

$708.45M
JAZZ annual earnings before interest & taxes is $708.45 million

EBITDA

$1.37B
JAZZ annual EBITDA is $1.37 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$12.01B
JAZZ annual total assets is $12.01 billion

Non current assets

$7.38B
JAZZ annual long term assets is $7.38 billion

Current assets

$4.63B
JAZZ annual total current assets is $4.63 billion

Cash and cash equivalents

$2.41B
JAZZ annual cash & cash equivalents is $2.41 billion

Accounts receivable

$716.76M
JAZZ annual accounts receivable is $716.76 million

Inventory

$480.44M
JAZZ annual inventory is $480.44 million

Liabilities

Total liabilities

$7.92B
JAZZ annual total liabilities is $7.92 billion

Long term liabilities

$6.88B
JAZZ annual total long term liabilities is $6.88 billion

Current liabilities

$1.04B
JAZZ annual total current liabilities is $1.04 billion

Accounts payable

$77.87M
JAZZ annual accounts payable is $77.87 million

Debt

Total debt

$6.16B
JAZZ annual total debt is $6.16 billion

Total debt 1-year change

+6.4%
JAZZ annual total debt is up +6.4% year-on-year

Long term debt

$6.12B
JAZZ annual long term debt is $6.12 billion

Short term debt

$45.78M
JAZZ annual short term debt is $45.78 million

Equity & Capital

Shareholders equity

$4.09B
JAZZ annual stockholders equity is $4.09 billion

Book value

$4.09B
JAZZ annual book value is $4.09 billion

Retained earnings

$1.13B
JAZZ annual retained earnings is $1.13 billion

Working capital

$3.59B
JAZZ annual working capital is $3.59 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$1.40B
JAZZ annual cash flow from operations is $1.40 billion

Cash from operations 1-year change

+27.83%
JAZZ annual cash flow from operations is up +27.83% year-on-year

Cash from investing

-$508.19M
JAZZ annual cash flow from investing activities is -$508.19 million

Cash from investing 1-year change

-211.66%
JAZZ annual cash flow from investing activities is down -211.66% year-on-year

Cash from financing

$20.52M
JAZZ annual cash flow from financing activities is $20.52 million

Cash from financing 1-year change

+106.72%
JAZZ annual cash flow from financing activities is up +106.72% year-on-year

CAPEX

CAPEX

$48.07M
JAZZ annual capital expenditures is $48.07 million

CAPEX 1-year change

+11.89%
JAZZ annual capital expenditures is up +11.89% year-on-year

Free Cash Flow

Free cash flow

$1.35B
JAZZ annual free cash flow is $1.35 billion

Free cash flow 1-year change

+28.48%
JAZZ annual free cash flow is up +28.48% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

89.05%
JAZZ annual gross profit margin is 89.05%

Operating margin

17.86%
JAZZ annual operating profit margin is 17.86%

Net margin

13.77%
JAZZ annual net profit margin is 13.77%

ROA & ROE

ROA

4.79%
JAZZ annual return on assets is 4.79%

ROE

14.31%
JAZZ annual return on equity is 14.31%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

11.69
JAZZ price to earnings ratio is 11.69

PE ratio Sector rank

20.59%
JAZZ price to earnings ratio is higher than 20.59% of companies in Healthcare sector

PB Ratio

PB ratio

1.52
JAZZ price to book ratio is 1.52

PB ratio Sector rank

56.47%
JAZZ price to book ratio is higher than 56.47% of companies in Healthcare sector

PS Ratio

PS ratio

1.53
JAZZ price to sales ratio is 1.53

PS ratio Sector rank

36.84%
JAZZ price to sales ratio is higher than 36.84% of companies in Healthcare sector

Enterprise value

Enterprise value

$9.99B
JAZZ enterprise value is $9.99 billion

Enterprise value Sector rank

92.15%
JAZZ enterprise value is higher than 92.15% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

7.30
JAZZ EV/EBITDA is 7.30

EV/EBITDA Sector rank

80.07%
JAZZ EV/EBITDA is higher than 80.07% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.46
JAZZ annual current ratio is 4.46

Quick ratio

3.99
JAZZ annual quick ratio is 3.99

Leverage

Debt to equity

1.49
JAZZ annual debt to equity ratio is 1.49

Interest coverage ratio

2.98
JAZZ annual interest coverage ratio is 2.98

Risk & Stability

Piotroski F-Score

7
JAZZ piotroski f-score is 7

Altman Z-Score

1.50
JAZZ altman z-score is 1.50

Analyst ratings

Recent major analysts updates

Apr 10, 25 Needham
Buy
Mar 10, 25 HC Wainwright & Co.
Buy
Mar 7, 25 UBS
Buy
Mar 6, 25 Truist Securities
Buy
Mar 5, 25 Needham
Buy
Feb 27, 25 Barclays
Overweight
Feb 26, 25 RBC Capital
Outperform
Feb 26, 25 Piper Sandler
Overweight
Feb 26, 25 Needham
Buy
Feb 26, 25 JP Morgan
Overweight

Institutional Ownership

Similar stocks

WAY logo
Waystar Holding (WAY)
BBIO logo
BridgeBio Pharma (BBIO)
LEGN logo
Legend Biotech (LEGN)
TGTX logo
TG Therapeutics (TGTX)
TFX logo
Teleflex Incorporated (TFX)
STVN logo
Stevanato Group SpA (STVN)
CORT logo
Corcept Therapeutics Incorporated (CORT)
MDGL logo
Madrigal Pharmaceuticals (MDGL)
BIO logo
Bio-Rad Laboratories (BIO)
  • What is the ticker symbol for Jazz Pharmaceuticals?
  • Does Jazz Pharmaceuticals pay dividends?
  • What sector is Jazz Pharmaceuticals in?
  • What industry is Jazz Pharmaceuticals in?
  • What country is Jazz Pharmaceuticals based in?
  • When did Jazz Pharmaceuticals go public?
  • Is Jazz Pharmaceuticals in the S&P 500?
  • Is Jazz Pharmaceuticals in the NASDAQ 100?
  • Is Jazz Pharmaceuticals in the Dow Jones?
  • When was Jazz Pharmaceuticals's last earnings report?
  • When does Jazz Pharmaceuticals report earnings?
  • Should I buy Jazz Pharmaceuticals stock now?

What is the ticker symbol for Jazz Pharmaceuticals?

The ticker symbol for Jazz Pharmaceuticals is NASDAQ:JAZZ

Does Jazz Pharmaceuticals pay dividends?

No, Jazz Pharmaceuticals does not pay dividends

What sector is Jazz Pharmaceuticals in?

Jazz Pharmaceuticals is in the Healthcare sector

What industry is Jazz Pharmaceuticals in?

Jazz Pharmaceuticals is in the Biotechnology industry

What country is Jazz Pharmaceuticals based in?

Jazz Pharmaceuticals is headquartered in Ireland

When did Jazz Pharmaceuticals go public?

Jazz Pharmaceuticals's initial public offering (IPO) was on June 1, 2007

Is Jazz Pharmaceuticals in the S&P 500?

No, Jazz Pharmaceuticals is not included in the S&P 500 index

Is Jazz Pharmaceuticals in the NASDAQ 100?

No, Jazz Pharmaceuticals is not included in the NASDAQ 100 index

Is Jazz Pharmaceuticals in the Dow Jones?

No, Jazz Pharmaceuticals is not included in the Dow Jones index

When was Jazz Pharmaceuticals's last earnings report?

Jazz Pharmaceuticals's most recent earnings report was on Feb 25, 2025

When does Jazz Pharmaceuticals report earnings?

The next expected earnings date for Jazz Pharmaceuticals is May 1, 2025

Should I buy Jazz Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page